相关产品推荐更多 >

CLIP Antibody, anti-human, PE, REAfinity™, 100 tests in 1 mL
询价
CD22 Antibody, anti-human, VioBlue®, REAfinity™, 100 tests in 200 µL
询价
CD52 Antibody, anti-human, Biotin, REAfinity™, 100 tests in 1 mL
询价
CD4 Antibody, anti-human, APC, REAlease®, 30 tests in 60 µL
询价
CD204 Antibody, anti-mouse, FITC, REAfinity™, 30 µg in 1 mL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
CD270 (HVEM)
- 亚型:
recombinant human IgG1
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REA275
- 标记物:
APC
- 适应物种:
mouse
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 浓度:
1:10
- 抗体英文名:
CD270 (HVEM) Antibody, anti-mouse, REAfinity™
- 抗体名:
CD270 (HVEM) Antibody, anti-mouse, REAfinity™
- 规格:
30 µg in 1 mL
Identification and enumeration of CD270 (HVEM)+ cells by flow cytometryClone REA275 recognizes the CD270 antigen, a type I transmembrane protein of the TNF-receptor superfamily which is also known as Herpes virus entry mediator (HVEM) or tumor necrosis factor receptor like 2 (TR2). CD270 is expressed in multiple tissues and cell lines and shows a constitutive and relatively high expression in peripheral blood T cells, B cells, monocytes, neutrophils and dendritic cells. Both human and mouse forms of CD270 can mediate entry of herpes simplex virus-1 and -2 (HSV-1 and HSV-2). CD270 transmits both activating and inhibitory signals; e.g interaction with receptors such as BTLA or CD160 attenuates TCR-mediated signaling, whereas interaction with receptor LIGHT allows co-stimulation of T and B cells. | Additional information: Clone REA275 displays negligible binding to Fc receptors. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Hsu, H. et al. (1997) ATAR, a novel tumor necrosis factor receptor family member, signal through TRAF2 and TRAF5. J. Biol. Chem. 272: 13471–13474. | Kwon, B. S. et al. (1997) A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272: 14272–14276. | Kim, W. K. et al. (2012) Absence of herpes virus entry mediator (HVEM) increases bone mass by attenuating receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis. Endocrinology 153 (10): 4808–4817.
技术资料暂无技术资料 索取技术资料
文献支持
CD270 (HVEM) Antibody, anti-mouse, APC, REAfinity™, 30 µg in 1 mL
询价





